Source:http://linkedlifedata.com/resource/pubmed/id/19497632
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-7-14
|
pubmed:abstractText |
Vascular calcification is frequently accompanied by intima-media thickening, but the associations among these atherosclerotic features and bone-related peptides in diabetic patients are unclear. We enrolled 168 type 2 diabetic patients and 40 non-diabetic subjects consecutively admitted to our hospital. Mean intima-media thickness (mean-IMT) in common carotid arteries was measured by B-mode ultrasonography. Agatston coronary artery calcium score (CACS) was obtained using multidetector-row computed tomography (MDCT). Plasma bone-related peptides osteopontin and osteoprotegerin levels were measured. Diabetic patients had higher mean-IMT (p=0.0002) and log(CACS+1) (p<0.0001) and similar bone-related peptides compared to non-diabetic subjects. In diabetic patients classified into tertiles according to their CACS levels, those with the highest scores showed the highest mean-IMT (p=0.0004) and bone-related peptides (p<0.05) among the groups. log(CACS+1) and mean-IMT were associated (p<0.0001) and were positively correlated with osteopontin (p<0.01) and osteoprotegerin (p<0.01) in diabetic patients. Multivariate analyses revealed that the significant independent determinants of log(CACS+1) were age, duration of diabetes and osteopontin (p<0.0001) and those of mean-IMT were age, hypertension, osteopontin and osteoprotegerin (p<0.0001), respectively. We have demonstrated that vascular calcification in type 2 diabetic patients is frequently accompanied by intima-media thickening, and osteopontin may act as a vascular calcification inhibitor by increasing intima-media thickness.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1872-8227
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
189-96
|
pubmed:meshHeading |
pubmed-meshheading:19497632-Adult,
pubmed-meshheading:19497632-Age of Onset,
pubmed-meshheading:19497632-Aged,
pubmed-meshheading:19497632-Atherosclerosis,
pubmed-meshheading:19497632-Calcinosis,
pubmed-meshheading:19497632-Coronary Artery Disease,
pubmed-meshheading:19497632-Diabetes Mellitus, Type 2,
pubmed-meshheading:19497632-Diabetic Angiopathies,
pubmed-meshheading:19497632-Female,
pubmed-meshheading:19497632-Hemoglobin A, Glycosylated,
pubmed-meshheading:19497632-Humans,
pubmed-meshheading:19497632-Male,
pubmed-meshheading:19497632-Middle Aged,
pubmed-meshheading:19497632-Multivariate Analysis,
pubmed-meshheading:19497632-Osteopontin,
pubmed-meshheading:19497632-Osteoprotegerin,
pubmed-meshheading:19497632-Tomography, X-Ray Computed
|
pubmed:year |
2009
|
pubmed:articleTitle |
Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients.
|
pubmed:affiliation |
Department of Diabetes and Endocrinology, Gifu University School of Medicine, Gifu, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|